Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bader, Michael Prof. Dr. (1) Luft, Friedrich Prof. Dr. (11) Müller, Dominik Prof. Dr. (12) (-) Dechend, Ralf Priv. Doz. (6) (-) Scheidereit, Claus Prof. Dr. (1) 1999 (1) 2000 (5) (-) 2001 (6) 2002 (7) 2003 (3) 2004 (3) 2005 (8) 2006 (1) 2008 (11) 2009 (12) 2010 (9) 2011 (11) 2012 (16) 2013 (16) 2014 (18) 2015 (15) 2016 (20) 2017 (16) 2018 (11) 2019 (16) 2020 (19) 2021 (13) 2022 (11) 2023 (11) 2024 (3) AG Müller/Dechend (ECRC) (6) Biology of Malignant Lymphomas (1) Cellular Neurosciences (26) Hypertension-caused End-Organ Damage (6) (-) Hypertension-Mediated End-Organ Damage (6) Integrative Vascular Biology (1) 6 Results: Active Filter: Dechend, Ralf Priv. Doz.Scheidereit, Claus Prof. Dr.Hypertension-Mediated End-Organ Damage2001 Sort: Result score Newest to oldest Oldest to newest April 01, 2001 / Contrib Nephrol Angiotensin-induced inflammation and vascular injury D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller January 01, 2001 / Hypertension Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury A. Fiebeler F. Schmidt D.N. Mueller J.K. Park R. Dechend M. Bieringer E. Shagdarsuren V. Breu H. Haller F.C. Luft January 01, 2001 / Adv Nephrol Necker Hosp Angiotensin-induced inflammation and novel approaches to treatment D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft
April 01, 2001 / Contrib Nephrol Angiotensin-induced inflammation and vascular injury D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft
January 01, 2001 / Am J Hypertens Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition R. Dechend A. Fiebler C. Lindschau H. Bischoff D.N. Mueller J.K. Park R. Dietz H. Haller F.C. Luft
January 01, 2001 / FASEB J Aspirin inhibits NF-kappa B and protects from angiotensin II-induced organ damage D.N. Mueller V. Heissmeyer R. Dechend F. Hampich J.K. Park A. Fiebeler E. Shagdarsuren J. Theuer M. Elger B. Pilz V. Breu K. Schroer D. Ganten R. Dietz H. Haller C. Scheidereit F.C. Luft
January 01, 2001 / Circulation Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor R. Dechend A. Fiebeler J.K. Park D.N. Muller J. Theuer E. Mervaala M. Bieringer D. Gulba R. Dietz F.C. Luft H. Haller
January 01, 2001 / Hypertension Mineralocorticoid receptor affects AP-1 and nuclear factor-kappa B activation in angiotensin II-induced cardiac injury A. Fiebeler F. Schmidt D.N. Mueller J.K. Park R. Dechend M. Bieringer E. Shagdarsuren V. Breu H. Haller F.C. Luft
January 01, 2001 / Adv Nephrol Necker Hosp Angiotensin-induced inflammation and novel approaches to treatment D.N. Mueller R. Dechend A. Fiebeler J.K. Park H. Haller F.C. Luft